FDA Inspection
Opto-Pharm Pte Ltd.FDA Inspection 1178651 - Opto-Pharm Pte Ltd. - September 01, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Opto-Pharm Pte Ltd., with an inspection on September 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 3f4fae1e-2dde-411d-aeb6-4195a22ee1c3
Violation Codes10
21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.18221 CFR 211.19221 CFR 211.198(a)21 CFR 211.22(c)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)
Full citation text and observation details available on the Dashboard.